Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating Subcutaneous MOA-728 for the Treatment of Opioid-Induced Constipation (OIC) in Subjects With Chronic Non-Malignant Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Adult outpatients with opioid-induced constipation and chronic non-malignant pain.~* Taking oral, transdermal, intravenous, or subcutaneous opioids.~* Willingness to discontinue all pre-study laxative therapy and use only study permitted rescue laxatives.~Exclusion Criteria~* History of chronic constipation before the initiation of opioid therapy.~* Other GI disorders known to affect bowel transit.~* Women who are pregnant, breast-feeding, or plan to become pregnant.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: PLACEBO_COMPARATOR): None
- 2 (Type: EXPERIMENTAL): None
- 3 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).